Cell cycle studies in myelodysplastic syndrome

David R. Head(University of Southern California), Keith Shults(Center for Innovation), Greg Stelzer(Center for Innovation), James W. Jacobberger(University Hospitals Cleveland Medical Center), Sara A. McClintock-Treep(Vanderbilt University), Fan Jiang(Hainan Medical University), Madan Jagasia(Vanderbilt University Medical Center), R C Briggs(Vanderbilt University), S. Goodman(Vanderbilt University Medical Center), Leanne A. Flye(Center for Innovation), Fouad Boulos(Vanderbilt University)
Leukemia Research
April 1, 2006
10.1016/s0145-2126(06)80026-3
Cited by 0

Related Papers

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Epidemiology of COVID-19 Among Children in China
|PEDIATRICS|2020|4.3k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
|Blood|1997|869